Pulmonary hypertension - a metabolic systems analysis

Hanne Hee Henriksen, Igor Marín de Mas, Pär Ingemar Johansson, Jørn Carlsen

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

Background
Pulmonary hypertension (PH) is classified into five different clinical groups, including pulmonary arterial hypertension (PAH) and chronic thromboembolic PH (CTEPH). PH is characterized by a modulation in the small pulmonary arteries, including the endothelium layer.

Methods
This prospective observational study includes 35 PH patients with either PAH or CTEPH. We have previously developed a platform to study the endothelium cell (EC) by reconstructing the most comprehensive endothelial genome-scale metabolic model (EC-GEM). Since the EC is in direct contact with the blood flow, we can adjust the EC-GEM by measuring extracellular metabolites from the blood and calculating the intracellular metabolic flux in the EC. We conducted individual EC-GEM models, i.e., in total 35 different models. Additionally, each model was widely analyzed; in total, 190 different intracellular activities were investigated. This enables us to develop a heatmap of the intracellular activities at individual patient levels. Patients with similar intracellular endothelial activities were combined.

Results
Four distinct intracellular phenotypes were identified; all were independent of the clinical classification of PH. We observed clinically relevant differences in the NT-pro BNP levels and the WHO functional classification between these phenotypes. Also, different important cellular activities were identified separating the four phenotypes. Two phenotypes were characterized by catabolic crisis and extreme citric acid cycle turnover for energy production. However, one of these also suffered from oxidative stress.

Conclusion
In PH patients metabolic systems analysis identified four metabolic phenotypes that correlated with NT-pro BNP levels and the WHO functional classification but were independent of the clinical diagnosis. This novel finding may enable us to identify metabolic therapeutic targets specific to the respective phenotypes and thus promote personalized medicine in patients with PH.
Original languageEnglish
JournalJournal of the American College of Cardiology
Volume79
Issue number9
Pages (from-to)1660
Number of pages1
ISSN0735-1097
DOIs
Publication statusPublished - 2022

Fingerprint

Dive into the research topics of 'Pulmonary hypertension - a metabolic systems analysis'. Together they form a unique fingerprint.

Cite this